| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Total operating expenses | 10,075 | 10,419 | 17,417 | 16,040 |
| Operating loss | -10,075 | -10,419 | -17,417 | -16,040 |
| Interest expense | 1,891 | 1,246 | 1,260 | 1,247 |
| Total other income (expense) | -1,891 | -1,246 | -1,260 | -1,247 |
| Net loss before income tax | -11,966 | -11,665 | -18,677 | -17,287 |
| Income tax expense | - | 0 | - | - |
| Net loss | -11,966 | -11,665 | -18,677 | -17,287 |
| Basic loss per share (in dollars per share) | 0 | 0 | 0 | 0 |
| Diluted loss per share (in dollars per share) | 0 | 0 | 0 | 0 |
| Weighted average common shares outstanding - basic (in shares) | 83,548,469 | 83,548,469 | 81,348,469 | 81,348,469 |
| Weighted average common shares outstanding - diluted (in shares) | 83,548,469 | 83,548,469 | 81,348,469 | 81,348,469 |
Nu-Med Plus, Inc. (NUMD)
Nu-Med Plus, Inc. (NUMD)